Archive for the ‘Latest News’

Maynooth Patient Seminar – 24th May 2018

15th May 2018

Bookings are now open for our Patient Information Seminar, at The Glenroyal Hotel, Maynooth, Co. Kildare on the 24th of May. Bookings here  or call 01 8941280 to book a place. This seminar will provide you with a comprehensive overview and understanding of migraine and offer you the opportunity to ask questions from one of Ireland's most experienced migraine nurses. The speaker for the evening is Jane Melling who is the migraine... [read more]


Cluster Headache: Fostering Empathy through Patients’ own Stories

20th April 2018

If you want to understand what it really means to live with cluster headache, imagine... fostering empathy through European patients’ own stories of their experiences Cluster headache (CH) is regarded as the most severe pain known to mankind. The severity of the pain has earned it the nickname “suicide headache”. Unfortunately there is a lack of empathy for people who suffer from CH and this affects how they are treated by friends,... [read more]


New Drugs for Migraine on the Way

6th December 2017

Calcitonin gene-related receptor (CGRP) antagonists are the most important medications in advanced stage clinical development for the treatment of both the acute migraine attack and the prevention of frequent attacks. Clinical trials on two of the antibodies have now been published in the New England Journal of Medicine. One antibody, Erenumab made by Novartis, was trialed on 955 patients with episodic migraine. At the start of the... [read more]


Press Release: Global Burden of Migraine Patient Survey

Migraine
14th November 2017

14th November, 2017 Press Release The Migraine Association of Ireland urges migraine sufferers to take part in the first Global Burden of Migraine Patient Survey. The Migraine Association of Ireland is please to support the Novartis, Worldwide Burden of Migraine Patient Survey. This global survey of migraine patients has been launched by Novartis in partnership with the European Headache Alliance. The EHA is a not for profit, umbrella... [read more]


Value of Treatment Report 2017

26th July 2017

"The Care Pathway for most European people with headache is a series of dead ends." "Headaches are often trivialized as “normal” and seen in those who complain of them as merely an excuse to avoid responsibility." "Governments, even if aware of it, do not acknowledge the substantial burden of headache on society" "Despite the recognition of the importance of the primary care setting for treating headache, there is a knowledge gap... [read more]


Archive for the ‘Latest News’

Maynooth Patient Seminar – 24th May 2018

15th May 2018

Bookings are now open for our Patient Information Seminar, at The Glenroyal Hotel, Maynooth, Co. Kildare on the 24th of May. Bookings here  or call 01 8941280 to book a place. This seminar will provide you with a comprehensive overview and understanding of migraine and offer you the opportunity to ask questions from one of Ireland's most experienced migraine nurses. The speaker for the evening is Jane Melling who is the migraine... [read more]


Cluster Headache: Fostering Empathy through Patients’ own Stories

20th April 2018

If you want to understand what it really means to live with cluster headache, imagine... fostering empathy through European patients’ own stories of their experiences Cluster headache (CH) is regarded as the most severe pain known to mankind. The severity of the pain has earned it the nickname “suicide headache”. Unfortunately there is a lack of empathy for people who suffer from CH and this affects how they are treated by friends,... [read more]


New Drugs for Migraine on the Way

6th December 2017

Calcitonin gene-related receptor (CGRP) antagonists are the most important medications in advanced stage clinical development for the treatment of both the acute migraine attack and the prevention of frequent attacks. Clinical trials on two of the antibodies have now been published in the New England Journal of Medicine. One antibody, Erenumab made by Novartis, was trialed on 955 patients with episodic migraine. At the start of the... [read more]


Press Release: Global Burden of Migraine Patient Survey

Migraine
14th November 2017

14th November, 2017 Press Release The Migraine Association of Ireland urges migraine sufferers to take part in the first Global Burden of Migraine Patient Survey. The Migraine Association of Ireland is please to support the Novartis, Worldwide Burden of Migraine Patient Survey. This global survey of migraine patients has been launched by Novartis in partnership with the European Headache Alliance. The EHA is a not for profit, umbrella... [read more]


Value of Treatment Report 2017

26th July 2017

"The Care Pathway for most European people with headache is a series of dead ends." "Headaches are often trivialized as “normal” and seen in those who complain of them as merely an excuse to avoid responsibility." "Governments, even if aware of it, do not acknowledge the substantial burden of headache on society" "Despite the recognition of the importance of the primary care setting for treating headache, there is a knowledge gap... [read more]